81. Prevalent osteoporosis and fracture risk in patients with hepatic cirrhosis: a systematic review and meta-analysis.
作者: Amirhossein Shirinezhad.;Fatemeh Mousavi Eshlaghi.;Dorsa Salabat.;Alireza Azarboo.;Zahra Fotoohi Ardakani.;Sina Esmaeili.;Amir Human Hoveidaei.;Amirhossein Ghaseminejad-Raeini.
来源: BMC Gastroenterol. 2025年25卷1期115页
Hepatic liver cirrhosis can lead to significant systemic complications, including the deterioration of bone health. The resulting bone complications can contribute to a decreased quality of life and increased healthcare burden. This study aimed to systematically review and analyze the risk of osteoporosis, fracture, and changes in bone mineral density (BMD) among patients with hepatic cirrhosis compared to non-cirrhotic healthy controls.
82. The impact of pancreatic duct stent placement on the clinically relevant postoperative pancreatic fistula rate for high-risk anastomoses: a systematic review and meta-analysis.
作者: Yuran Dai.;Xiaozhi Lu.;Lei Jiang.;Zipeng Lu.;Kuirong Jiang.;Yi Miao.;Jishu Wei.
来源: BMC Gastroenterol. 2025年25卷1期116页
To evaluate the impact of pancreatic duct stent outcomes on the prognosis of postoperative pancreatic fistula in patients with high-risk anastomoses.
83. Risk of stroke in patients with inflammatory bowel disease: a systematic review and meta-analysis.
作者: Chao Luo.;Lingpei Liu.;Di Zhu.;Zuanmin Ge.;Yuehua Chen.;Feng Chen.
来源: BMC Gastroenterol. 2025年25卷1期114页
Current studies suggest a potential link between inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), and cardiovascular diseases, such as stroke. This study aimed to assess the risk of stroke in IBD patients compared to general population.
84. Casual effect of ulcerative colitis on chronic heart failure: results from a bidirectional Mendelian randomization study.
作者: Yuzhou Chu.;Jianhua Li.;Li Gong.;Sheng Shao.;Hao Chen.;Pengfei He.;Juntao Yan.
来源: BMC Gastroenterol. 2025年25卷1期95页
This study aimed to detect the causal effect of ulcerative colitis (UC) on heart failure. A bidirectional two-sample Mendelian randomization (MR) analysis was performed. The causal impact of UC on heart failure was determined via MR by performing a genome-wide association study in which 4 UCs descending from European ancestors were set as individual exposures. The inverse-variance weighted (IVW) method was used as the main method, and 4 other methods were set as assistant parameters. Susbequently, the MR results were combined with meta-analysis results. The MR Egger method was employed to investigate pleiotropy. The leave-one-out method was utilized for sensitivity analysis. Furthermore, a reverse-directional study was conducted. There was evidence of the causal effect of UC on heart failure in MR estimates using 4 UC datasets. The IVW method revealed that the odds ratio (OR) = 1.03, 95% confidence interval (CI) = 1.01-1.06, P = 0.0441 when the first UC dataset was used; OR = 1.03, 95% CI = 1.01-1.05, P = 0.0445 when the second UC dataset was used; OR = 2046, 95% CI = 1.37-3.05E + 06, P = 0.0409 when the third UC dataset was used; and OR = 8.12E + 04, 95% CI = 29.09-2.27E + 08, P = 0.0052 when the fourth UC dataset was used. A meta-analysis of 4 MR studies revealed that UC had a statistically significant causal effect on heart failure (OR = 1.03, 95% CI = 1.01-1.05; P = 0.0074). Reverse MR analysis revealed that heart failure did not have a causal effect on UC. There was no pleiotropy. This MR study demonstrated that UC had a causal effect on heart failure and that there was no reverse causal effect.
85. Systematic review and meta-analysis: no evidence that low-dose non-steroidal anti-inflammatory drugs (NSAIDs) reduce the risk of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).
Currently, many studies focus on the use of high-dose NSAIDs, showing significant effectiveness in preventing post-ERCP pancreatitis after surgery. However, some studies suggest that low-dose NSAIDs can also have certain effects. Nevertheless, after using propensity score matching to balance potential biases, the results do not seem ideal and fail to demonstrate clear effectiveness.
86. Short- and long-term outcomes of neoadjuvant chemotherapy compared with neoadjuvant chemoradiotherapy for locally advanced rectal cancer: an updated meta-analysis.
作者: Yue Guo.;Zhifeng Guo.;Jiaojiao Zhang.;Guowu Qian.;Wangquan Ji.;Linlin Song.;Zhe Guo.;Zhuo Han.
来源: BMC Gastroenterol. 2025年25卷1期87页
Neoadjuvant chemoradiotherapy (NACRT) is the standard treatment regimen for locally advanced rectal cancer (LARC) but has unavoidable radiation toxicity. With the advent of more optimized chemotherapy regimens, neoadjuvant chemotherapy (NAC) is sometimes offered as an alternative to NACRT. The purpose of this meta-analysis was to compare the short- and long-term outcomes of NAC and NACRT for LARC patients.
87. Health-related quality of life in pediatric patients with intestinal failure without neurodevelopmental delay: a systematic review and meta-analysis.
作者: Francesco Milo.;Deny Menghini.;Teresa Capriati.;Lorenzo Norsa.;Francesco Proli.;Giovanni Boroni.;Maria Immacolata Spagnuolo.;Giovanna Verlato.;Antonella Lezo.;Claudio Romano.;Stefano Vicari.;Antonella Diamanti.
来源: BMC Gastroenterol. 2025年25卷1期80页
Intestinal failure (IF) is a broad term encompassing various conditions that hinder the body's ability to absorb nutrients for growth and maintenance. These conditions can significantly affect child's well-being, leading to physical limitations, psychological distress, and social isolation. We aimed to evaluate the available data on health-related quality of life (HRQoL) in pediatric patients with IF and without neurodevelopmental delay.
88. Global prevalence of Fusobacterium nucleatum and Bacteroides fragilis in patients with colorectal cancer: an overview of case reports/case series and meta-analysis of prevalence studies.
作者: Fatemeh Sameni.;Parisa Abedi Elkhichi.;Ali Dadashi.;Mohammad Sadeghi.;Mehdi Goudarzi.;Maedeh Pourali Eshkalak.;Masoud Dadashi.
来源: BMC Gastroenterol. 2025年25卷1期71页
Colorectal cancer (CRC) is the second deadliest carcinoma across the globe and has been known as a multi-factor induced-disease. Emerging research have demonstrated that bacterial colonization may contribute to the initiation and promotion of the CRC. The presence of Fusobacterium nucleatum (F. nucleatum) and Bacteroides fragilis (B. fragilis) in the gut is associated with the development of CRC. In this study, the prevalence of F. nucleatum and B. fragilis among CRC patients has been assessed worldwide through a systematic review and meta-analysis.
89. Efficacy analysis of folic acid in chronic atrophic gastritis with Helicobacter pylori infection: a systematic review and meta-analysis.
Current data indicate that supplements such as folic acid play a significant role in treating chronic atrophic gastritis (CAG). However, no meta-analysis article evaluates its efficacy comprehensively. Therefore, we conducted a meta-analysis to compare the effectiveness and safety of folic acid in the treatment of CAG with Helicobacter pylori (H. pylori) infection.
90. Aberrant SNHG expression predicts poor prognosis in esophageal cancer using meta-analysis and bioinformatics analysis.
作者: Ke Shi.;Li-De Huang.;Dan Li.;Wei-Min Luo.;Hua-Song Liu.;Dong-Xiao Ding.;Qiang Guo.;Yue-Feng Liu.
来源: BMC Gastroenterol. 2025年25卷1期63页
Small nucleolar RNA host gene (SNHG) family were reported involved in various biological processes and may be used as a promising prognostic marker in esophageal cancer (EC). A meta-analysis was performed to investigate the relationship between SNHG expression and prognosis of EC in this study.
91. The serum hepcidin and the hepcidin/ferritin ratio in NAFLD: a systematic review and meta-analysis.
作者: Jingmin Song.;Heqing Wang.;Xiaolian Gao.;Fen Yang.;Xinhong Zhu.;Guiyuan Qiao.;Ting Gan.;Junxiu Tao.
来源: BMC Gastroenterol. 2025年25卷1期62页
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of chronic liver diseases characterized by hepatic steatosis exceeding 5% in the absence of alcohol and other liver-damaging factors. Clinical studies have identified a potential link between abnormal iron metabolism and the high incidence of NAFLD; however, the results from clinical trials remain inconsistent. This meta-analysis aims to compare serum hepcidin levels and the hepcidin/ferritin ratio between adults with NAFLD and those without to explore their potential relationship with NAFLD.
92. Mechanistic investigation and the optimal dose based on baicalin in the treatment of ulcerative colitis-A preclinical systematic review and meta-analysis.
作者: Jinchen Chong.;Zepeng Chen.;Jiaze Ma.;Linhai He.;Yijia Zhu.;Zhihua Lu.;Zhengxi Qiu.;Chen Chen.;Yugen Chen.;Feng Jiang.
来源: BMC Gastroenterol. 2025年25卷1期50页
Ulcerative colitis (UC) is a type of inflammatory bowel disease, and current treatments often fall short, necessitating new therapeutic options. Baicalin shows therapeutic promise in UC animal models, but a systematic review is needed.
93. Prevalence of common diarrheagenic enterobacteriaceae in Iran (2000-2023): a systematic review and meta-analysis.
作者: Mozhgan Derakhshan-Sefidi.;Fereshteh Eidy.;Somayyeh Nadi-Ravandi.;Sareh Bagheri-Josheghani.;Maryam Mirfakhraei.
来源: BMC Gastroenterol. 2025年25卷1期43页
Bacterial gastroenteritis is a significant public health concern, capable of causing severe infections. Among the various pathogens involved, those belonging to the Enterobacteriaceae family are the most frequently isolated and associated with gastrointestinal disorders. This study aimed to investigate the prevalence of common diarrheagenic Enterobacteriaceae in Iran over the past two decades, from 2000 to 2023.
94. The prognostic value of systemic inflammation response index in digestive system carcinomas: a systematic review and meta-analysis.
作者: Zuo-Hu Niu.;Li Lin.;Hong-Ye Peng.;Xin-Zhuo Zheng.;Mi-Yuan Wang.;Feng-Xia Sun.;Chun-Jun Xu.
来源: BMC Gastroenterol. 2025年25卷1期34页
Digestive system carcinomas (DSC) constitute a significant proportion of solid tumors, with incidence rates rising steadily each year. The systemic inflammation response index (SIRI) has been identified as a potential prognostic marker for survival in various types DSC. This meta-analysis aimed to evaluate the prognostic value of SIRI in patients with DSC.
95. The role of exercise-based prehabilitation in enhancing surgical outcomes for patients with digestive system cancers: a meta-analysis.
作者: Shasha Xu.;Rong Yin.;Haiou Zhu.;Yin Gong.;Jing Zhu.;Changxian Li.;Qin Xu.
来源: BMC Gastroenterol. 2025年25卷1期26页
Prehabilitation is a crucial component of tumor rehabilitation that attempts to improve patients' preoperative health, although its efficacy in treating patients with cancers of the digestive system is still up for debate.
96. Eradication Therapy to Prevent Gastric Cancer in Helicobacterpylori-Positive Individuals: Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies.
作者: Alexander C Ford.;Yuhong Yuan.;Jin Young Park.;David Forman.;Paul Moayyedi.
来源: Gastroenterology. 2025年169卷2期261-276页
Screening for, and treating, Helicobacter pylori in the general population or patients with early gastric neoplasia could reduce incidence of, and mortality from, gastric cancer. We updated a meta-analysis of randomized controlled trials (RCTs) examining this issue.
97. Investigating neutropenic enterocolitis: a systematic review of case reports and clinical insights.
作者: Samane Nematolahi.;Ali Amanati.;Hossein Molavi Vardanjani.;Mohammadreza Pourali.;Mahnaz Hosseini Bensenjan.;Farnoosh Nozari.;Mohebat Vali.;Seyed Reza Abdipour Mehrian.;Seyed Ali Nabavizadeh.;Farima Safari.
来源: BMC Gastroenterol. 2025年25卷1期17页
Neutropenic enterocolitis is a serious gastrointestinal complication that can develop in patients undergoing chemotherapy or other immunosuppressive treatments. It is characterized by inflammation and necrosis of the bowel, and most commonly affects the cecum and ascending colon. Although individual case reports have described the features of NE, a comprehensive synthesis of all the published cases is required.
98. Prognostic value of albumin-bilirubin grade in patients with cholangiocarcinoma: a systematic review and meta-analysis.
作者: Mahyaar Omouri-Kharashtomi.;Seyedeh Yasaman Alemohammad.;Negin Moazed.;Inas Afzali Nezhad.;Hamed Ghoshouni.
来源: BMC Gastroenterol. 2025年25卷1期19页
Cholangiocarcinoma (CCA) is a type of cancer that develops in the biliary tract. CCA accounts for 10% of primary hepatic cancers and is characterized by its aggressive nature and poor prognosis. This systematic review and meta-analysis aims to assess the prognostic value of the novel hepatic function assessment measure known as albumin-bilirubin (ALBI) grade in patients with CCA.
99. Associations between changes in the gut microbiota and liver cirrhosis: a systematic review and meta-analysis.
作者: Ye Liu.;Ziwei Chen.;Chang Li.;Tianhan Sun.;Xuanmei Luo.;Boyue Jiang.;Meilan Liu.;Qing Wang.;Tong Li.;Jianfu Cao.;Yayu Li.;Yuan Chen.;Lu Kuai.;Fei Xiao.;Hongtao Xu.;Hongyuan Cui.
来源: BMC Gastroenterol. 2025年25卷1期16页
Summaries of the relationships between the microbiota and liver cirrhosis and their conclusions are not consistent. This study describes microbial differences in patients with liver cirrhosis by performing a meta-analysis.
100. Inflammatory bowel disease increases the risk of pancreatitis: a two-sample bidirectional Mendelian randomization analysis.
Previous studies have suggested an association between inflammatory bowel disease (IBD), and pancreatitis, including acute pancreatitis (AP) and chronic pancreatitis (CP). We aimed to examine the potential causal relationship between IBD and pancreatitis using the Mendelian randomization (MR) method.
|